Molecular and Clinical Implications of Variant Repeats in Myotonic Dystrophy Type 1.

DMPK gene age at onset genetic modifier myotonic dystrophy type 1 phenotype variability repeat expansions repeat interruptions somatic mosaicism variant repeats

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
29 Dec 2021
Historique:
received: 10 11 2021
revised: 14 12 2021
accepted: 18 12 2021
entrez: 11 1 2022
pubmed: 12 1 2022
medline: 10 2 2022
Statut: epublish

Résumé

Myotonic dystrophy type 1 (DM1) is one of the most variable monogenic diseases at phenotypic, genetic, and epigenetic level. The disease is multi-systemic with the age at onset ranging from birth to late age. The underlying mutation is an unstable expansion of CTG repeats in the

Identifiants

pubmed: 35008780
pii: ijms23010354
doi: 10.3390/ijms23010354
pmc: PMC8745394
pii:
doi:

Substances chimiques

Myotonin-Protein Kinase EC 2.7.11.1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : The Ministry of Education, Science and Technological Development of the Republic of Serbia
ID : 451-03-9/2021-14/200178

Références

Rare Dis. 2013 Sep 26;1:e26555
pubmed: 25003008
Biochim Biophys Acta. 2015 Apr;1852(4):594-606
pubmed: 24882752
Cell. 1992 Apr 17;69(2):385
pubmed: 1568252
Nat Genet. 1993 Nov;5(3):254-8
pubmed: 8275090
Nat Genet. 1993 Jun;4(2):140-2
pubmed: 8348151
Nat Genet. 2001 Aug;28(4):335-43
pubmed: 11479593
Am J Hum Genet. 2009 Nov;85(5):606-16
pubmed: 19853235
Am J Med Genet A. 2009 Jul;149A(7):1365-74
pubmed: 19514047
EMBO Mol Med. 2021 Nov 8;13(11):e14095
pubmed: 34632710
Neurol Sci. 2017 Mar;38(3):415-423
pubmed: 27896491
Acta Myol. 2020 Mar 01;39(1):13-18
pubmed: 32607474
Methods Mol Biol. 2004;277:61-76
pubmed: 15201449
Stem Cell Reports. 2015 Aug 11;5(2):221-31
pubmed: 26190529
Front Genet. 2018 Nov 27;9:601
pubmed: 30546383
Neurology. 2019 Sep 3;93(10):e995-e1009
pubmed: 31395669
Hum Mol Genet. 2019 Jul 1;28(13):2245-2254
pubmed: 31220271
Hum Mutat. 2020 Feb;41(2):420-431
pubmed: 31608518
Mol Cell Probes. 2011 Aug;25(4):182-5
pubmed: 21550396
Rev Neurol (Paris). 2016 Oct;172(10):572-580
pubmed: 27665240
Hum Mol Genet. 2010 Apr 15;19(8):1399-412
pubmed: 20080938
Front Neurol. 2018 Jun 19;9:463
pubmed: 29973908
Nat Genet. 1996 Nov;14(3):285-91
pubmed: 8896557
J Neuromuscul Dis. 2014;1(1):3-13
pubmed: 25729645
Eur J Hum Genet. 2013 Nov;21(11):1272-6
pubmed: 23443018
Nat Biotechnol. 2019 Dec;37(12):1478-1481
pubmed: 31740840
Genes (Basel). 2020 Aug 13;11(8):
pubmed: 32823742
J Neurol. 2013 May;260(5):1245-57
pubmed: 23263591
Muscle Nerve. 2018 Oct;58(4):517-522
pubmed: 30028904
Hum Mol Genet. 1995 Jan;4(1):1-8
pubmed: 7711720
Hum Mol Genet. 1995 Jan;4(1):135-6
pubmed: 7711725
Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):260-5
pubmed: 21173221
Eur J Neurol. 2005 Mar;12(3):236-7
pubmed: 15693817
Lancet Neurol. 2012 Oct;11(10):891-905
pubmed: 22995693
Neurology. 2000 Mar 28;54(6):1218-21
pubmed: 10746587
Science. 1991 May 24;252(5009):1097-102
pubmed: 2031184
Eur J Hum Genet. 2017 Feb;25(2):257-261
pubmed: 27876818
Am J Hum Genet. 1994 Mar;54(3):414-23
pubmed: 8116611
Hum Mol Genet. 1998 Feb;7(2):307-12
pubmed: 9425239
Neurol Genet. 2020 Aug 12;6(5):e504
pubmed: 32851192
Acta Neurol Scand. 2016 Nov;134(5):346-351
pubmed: 27696366
PLoS One. 2019 Jul 5;14(7):e0219446
pubmed: 31276570
Hum Mol Genet. 1995 Oct;4(10):1919-25
pubmed: 8595416
Diagn Mol Pathol. 2011 Mar;20(1):48-51
pubmed: 21326039
Eur J Hum Genet. 2008 Feb;16(2):215-22
pubmed: 18043721
Neuromuscul Disord. 2003 Dec;13(10):813-21
pubmed: 14678804
Ann Neurol. 1994 Jan;35(1):104-7
pubmed: 8285579
Neurol Res. 2015 Nov;37(11):939-44
pubmed: 26184384
Neurology. 2021 Feb 16;96(7):e1045-e1053
pubmed: 33472919
Am J Hum Genet. 1995 Jan;56(1):114-22
pubmed: 7825566
Am J Hum Genet. 1998 Feb;62(2):278-85
pubmed: 9463318
Am J Hum Genet. 2017 Mar 2;100(3):488-505
pubmed: 28257691
Hum Mol Genet. 2011 Jan 1;20(1):1-15
pubmed: 21044947
Am J Hum Genet. 2020 Oct 1;107(4):654-669
pubmed: 32937144
Neuromuscul Disord. 2021 Mar;31(3):232-238
pubmed: 33546847
Int J Neurosci. 2006 Dec;116(12):1509-18
pubmed: 17145685
Am J Hum Genet. 1993 Jun;52(6):1164-74
pubmed: 8503448
Science. 2001 Aug 3;293(5531):864-7
pubmed: 11486088
Neurol Sci. 2021 Dec;42(12):5365-5368
pubmed: 34386887
Hum Mol Genet. 2012 Aug 15;21(16):3558-67
pubmed: 22595968
Neurol Genet. 2021 Mar 9;7(2):e572
pubmed: 33884298
Hum Mutat. 2018 Jul;39(7):970-982
pubmed: 29664219
Science. 1992 Mar 6;255(5049):1256-8
pubmed: 1546326
Nature. 2012 Aug 2;488(7409):111-5
pubmed: 22859208
Acta Neuropathol. 2015 May;129(5):715-27
pubmed: 25716178
Genet Med. 2012 Aug;14(8):729-36
pubmed: 22498846
Neuromuscul Disord. 2005 Jan;15(1):5-16
pubmed: 15639115
Hum Mol Genet. 2020 Aug 29;29(15):2496-2507
pubmed: 32601694
Genet Test. 2007 Spring;11(1):84-90
pubmed: 17394397
Lancet Neurol. 2020 Nov;19(11):930-939
pubmed: 33098802
Science. 1992 Mar 6;255(5049):1253-5
pubmed: 1546325
Brain. 1989 Jun;112 ( Pt 3):779-97
pubmed: 2731029
Neurol Genet. 2019 May 23;5(3):e338
pubmed: 31334355
Eur J Hum Genet. 2018 Nov;26(11):1635-1647
pubmed: 29967337
Mol Ther Nucleic Acids. 2017 Dec 15;9:337-348
pubmed: 29246312
Am J Hum Genet. 1993 May;52(5):875-83
pubmed: 8098180
Neurogenetics. 2017 Dec;18(4):207-218
pubmed: 28942489
Int J Mol Sci. 2021 Mar 05;22(5):
pubmed: 33807660
Hum Mol Genet. 2021 Dec 27;31(2):262-274
pubmed: 34432028
Biochim Biophys Acta. 2015 Dec;1852(12):2645-52
pubmed: 26391753

Auteurs

Stojan Peric (S)

Faculty of Medicine, Neurology Clinic, University Clinical Centre of Serbia, University of Belgrade, 11 000 Belgrade, Serbia.

Jovan Pesovic (J)

Center for Human Molecular Genetics, Faculty of Biology, University of Belgrade, 11 000 Belgrade, Serbia.

Dusanka Savic-Pavicevic (D)

Center for Human Molecular Genetics, Faculty of Biology, University of Belgrade, 11 000 Belgrade, Serbia.

Vidosava Rakocevic Stojanovic (V)

Faculty of Medicine, Neurology Clinic, University Clinical Centre of Serbia, University of Belgrade, 11 000 Belgrade, Serbia.

Giovanni Meola (G)

Department of Biomedical Sciences for Health, University of Milan, 20100 Milan, Italy.
Department of Neurorehabilitation Sciences, Casa Di Cura del Policlinico, 20100 Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH